Skip to main content
UniHealth

Doctor search

Curtis Robert Chong, MD

Medical Oncology · Redwood City

NPI 1912167420

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
13
2 carriers
Offices
3

Offices

3 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Sequoia Hospital · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

13 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chong’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

13 of 13 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

California Medical Board record

Licence A143956 · Current

Licensed to practise in California · since 2016 · expires 2027-09-30 · Johns Hopkins University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Sequoia Hospital

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Sequoia Hospital
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths104.12 (51.8 to 156.44) · 56 casesBetterJul 2022 – Jun 2024
Clostridium Difficile (C.Diff)Infections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.95 (0 to 1.98) · 472 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.91 (0.58 to 1.24)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.8 · 68 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 72 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.1 · 258 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.5 · 171 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.3 · 81 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.2 · 1,231 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.23 (0.01 to 0.44) · 3,018 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.23 (0.03 to 0.44) · 3,164 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.59 (0.47 to 4.71) · 1,402 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.47 (0.04 to 2.9) · 926 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.68 (0.21 to 3.16) · 1,310 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.54 (4.42 to 14.67) · 978 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.98 (1.61 to 8.36) · 924 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.69 (0.19 to 3.19) · 192 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.57 (0 to 1.43) · 2,501 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.5 · 332 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.702No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.853No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.2 · 67 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.3 · 295 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-27.1 · 76 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-22.3 · 304 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-4.6 · 178 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.3 · 180 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 305 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 41 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.7 · 29 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.1 (9.7 to 17.7) · 129 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.2) · 713 casesNo differentJan 2024 – Dec 2024

What patients said (631 patients answered, 27% of those asked)

Patient survey stars by topic at Sequoia Hospital
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Sequoia Hospital
Room was "always" clean78%
Nurses "always" communicated well80%
Doctors "always" communicated well82%
Staff "always" explained60%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully81%
Doctors "always" treated them with courtesy and respect89%
Patients who gave a rating of "9" or "10" (high)77%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully77%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night55%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms91%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$370,075

Medicare paid this office $370,075 for 371 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)295$184,562$157
Return visit (30+ min)275$104,210$114
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's317$29,810$15
Short return visit (20+ min)130$22,980$80
New patient visit (60+ min)103$20,396$198
See all 6 services
Every Original Medicare service billed
Long return visit (40+ min)295$184,562$157
Return visit (30+ min)275$104,210$114
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's317$29,810$15
Short return visit (20+ min)130$22,980$80
New patient visit (60+ min)103$20,396$198
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or88$3,757$29

Who their Medicare patients are

371 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 15% · Women 49% · Also on Medicaid 35% · Health risk score 2.41. Above the middle of the specialty; the typical medical oncology clinician is at 2.11.

Conditions among them: High blood pressure 75% · Cancer 51% · Diabetes 42% · Coronary heart disease 39% · Chronic kidney disease 31% · Heart failure 21% · Atrial fibrillation 21% · COPD 17% · Depression 16% · Dementia 10% · Stroke 9%.

The office billed $2,087,348, Medicare allowed $479,411 and paid $370,075; for 4,691 services of 15 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243714,691752.41$2,087,348$370,075
20233522,966762.73$1,883,801$286,028
20224183,039752.72$1,785,422$275,493
20212382,630752.30$1,454,284$240,879
20202062,023762.08$824,650$169,492
2019171742752.63$191,209$65,602
2018153778733.17$427,245$59,317
2017111559742.00$298,235$42,786
2016115189753.35$86,195$18,781
2015108123733.03$70,114$16,140

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 12 services

Original Medicare services billed in 2023
Long return visit (40+ min)255$150,132$126
Return visit (30+ min)225$74,351$84
Short return visit (20+ min)156$22,580$55
New patient visit (60+ min)75$11,599$155
Long return visit (40+ min)24$5,328$130
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes27$5,065$108
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or113$4,844$27
New patient visit (60+ min)21$3,427$163
Initial hospital care with moderate level of medical decision making at least 75 minutes15$2,344$156
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes22$2,014$72
Return visit (30+ min)11$1,765$84
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or23$765$28

2022: 16 services

Original Medicare services billed in 2022
Long return visit (40+ min)208$90,709$128
Return visit (30+ min)222$72,565$84
Short return visit (20+ min)192$37,382$57
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes121$22,577$92
New patient visit (60+ min)91$15,453$170
Initial hospital care with moderate level of medical decision making at least 75 minutes47$8,549$178
New patient visit (60+ min)25$4,159$166
Long return visit (40+ min)22$4,137$133
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or73$3,912$28
Return visit (30+ min)21$3,776$90
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes28$2,696$64
Extended inpatient or observation hospital service, first hour19$1,737$83
Short return visit (20+ min)14$1,639$61
Hospital discharge day management, more than 30 minutes15$1,459$97
Short return visit21$831$31
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or15$620$28

2021: 10 services

Original Medicare services billed in 2021
Long return visit (40+ min)187$104,709$130
Return visit (30+ min)185$73,630$86
Short return visit (20+ min)153$32,077$58
New patient visit (60+ min)54$8,875$164
Long return visit (40+ min)28$5,888$137
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or63$4,248$29
Return visit (30+ min)26$3,764$86
New patient visit (60+ min)22$3,743$170
Short return visit30$1,893$33
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or16$1,019$30

2020: 7 services

Original Medicare services billed in 2020
Long return visit (40+ min)171$79,968$99
Return visit (30+ min)162$66,123$70
New patient visit (60+ min)52$7,837$151
Short return visit (20+ min)63$5,542$47
New patient visit (60+ min)23$3,573$155
Return visit (30+ min)21$2,261$73
Long return visit (40+ min)15$2,166$103

2019: 5 services

Original Medicare services billed in 2019
Long return visit (40+ min)103$39,858$97
Return visit (30+ min)76$12,351$67
New patient visit (60+ min)42$5,847$139
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes17$3,407$87
Short return visit (20+ min)27$1,724$41

2018: 4 services

Original Medicare services billed in 2018
Long return visit (40+ min)83$29,300$92
Return visit (30+ min)93$19,284$65
Short return visit (20+ min)40$3,997$41
New patient visit (60+ min)26$3,690$142

2017: 5 services

Original Medicare services billed in 2017
Return visit (30+ min)66$15,182$66
Long return visit (40+ min)64$14,752$93
New patient visit (60+ min)55$7,802$142
Short return visit (20+ min)36$3,464$43
Short return visit16$535$21

2016: 4 services

Original Medicare services billed in 2016
Initial hospital care with moderate level of medical decision making at least 75 minutes53$8,092$153
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes27$3,453$82
Critical care, first 30-74 minutes14$2,538$181
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes32$2,510$58

2015: 3 services

Original Medicare services billed in 2015
Initial hospital care with moderate level of medical decision making at least 75 minutes71$12,040$167
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes15$1,547$86
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes13$776$60

Medicaid work

$112,445 in 2024

Medicaid paid $112,445 for 2,032 billed services this clinician did in 2024, up to 70 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)885$80,019
Return visit (30+ min)510$28,183
Short return visit (20+ min)76$2,652
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)561$1,592
Medicaid work by year
20242,032470$112,445
20231,931468$85,929
20221,963649$87,809
20211,201333$49,126
2020349218$13,920
2019103114$6,163
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)956$51,394
Return visit (30+ min)672$25,829
Short return visit (20+ min)272$7,273
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES31$1,434

2022

Largest Medicaid services in 2022
Long return visit (40+ min)558$34,574
Return visit (30+ min)681$32,226
Short return visit (20+ min)502$14,327
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES122$5,658
Telehealth originating site facility fee81$1,024
Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr)19$0

2021

Largest Medicaid services in 2021
Long return visit (40+ min)422$23,406
Return visit (30+ min)489$18,914
Short return visit (20+ min)290$6,805

2020

Largest Medicaid services in 2020
Long return visit (40+ min)216$9,802
Return visit (30+ min)133$4,118

2019

Largest Medicaid services in 2019
Long return visit (40+ min)103$6,163

Drugs they prescribed that Part D paid

$1,375,390

Pharmacies billed $1,375,390 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 6% of their Part D prescriptions (116 of 2,038) in 2024. Above the middle of the specialty; the typical medical oncology clinician is at 6%. Long-acting opioids: 28% of their opioid prescriptions.

1,679 generic and fewer than 11 brand-name prescriptions · $1,375,390 in drug cost · 74 antibiotic prescriptions to 29 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Stivarga23$343,566$14,938
Creon54$102,616$1,900
Eliquis80$77,066$963
Zarxio26$34,790$1,338
Xarelto24$22,994$958
See all 48 drugs
Every Part D drug this clinician prescribed
Stivarga23$343,566$14,938
Creon54$102,616$1,900
Eliquis80$77,066$963
Zarxio26$34,790$1,338
Xarelto24$22,994$958
Enoxaparin51$11,332$222
Jardiance13$10,218$786
Mirtazapine50$1,976$40
Sucralfate14$1,652$118
Ondansetron118$1,494$13
Prochlorperazine Maleate136$1,381$10
Sodium Chloride35$1,223$35
Naloxone21$1,067$51
Nystatin18$1,017$56
Gabapentin71$928$13
Dexamethasone53$922$17
Potassium Chloride44$807$18
Morphine Sulfate Er28$719$26
Oxycodone51$630$12
Hydrocortisone18$623$35
Lactulose27$620$23
Celecoxib20$541$27
Ondansetron Odt13$538$41
Amlodipine Besylate66$483$7
Doxycycline Hyclate21$479$23
Lidocaine-Prilocaine35$438$13
Alendronate38$427$11
Chlorthalidone16$411$26
Hydrocodone-Acetaminophen14$408$29
Lisinopril37$408$11
Anastrozole18$341$19
Prednisone39$328$8
Loperamide16$265$17
Losartan16$261$16
Levothyroxine33$247$7
Atorvastatin36$236$7
Pantoprazole19$230$12
Metformin14$193$14
Metoprolol15$189$13
Tamsulosin22$166$8
Spironolactone23$165$7
Amoxicillin-Clavulanate Potass18$155$9
Furosemide34$136$4
Trazodone15$125$8
Lorazepam42$114$3
Tramadol13$78$6
Metformin Hcl Er15$61$4
Escitalopram12$38$3

Year by year

Part D prescribing by year
20242,0382416% (116)None$1,375,390
20231,9192137% (138)None$1,597,929
20221,74318011% (184)None$2,588,981
20211,36315011% (143)None$2,146,418
20201,0001279% (87)23%$1,438,738
2019333729% (31)25%$665,912
20183618813% (48)None$297,712
201746210511% (52)None$435,612
20163924NoneNone$46,501
20156216None24%$19,019
201420NoneNoneNone$9,208
20136913None25%$48,553

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 47 drugs

Part D drugs prescribed in 2023
Lenvima21$500,595$23,838
Stivarga22$357,015$16,228
Eliquis91$74,039$814
Creon34$35,914$1,056
Xarelto18$12,793$711
Enoxaparin35$10,651$304
Sodium Chloride70$3,090$44
Mirtazapine49$2,321$47
Pantoprazole26$1,889$73
Lactulose34$1,692$50
Naloxone20$1,656$83
Gabapentin83$1,645$20
Oxycodone65$1,548$24
Prochlorperazine Maleate116$1,353$12
Dexamethasone44$1,182$27
Amlodipine Besylate78$1,048$13
Ondansetron100$968$10
Potassium Chloride34$929$27
Morphine Sulfate Er36$923$26
Hydrocortisone19$812$43
Atorvastatin32$790$25
Celecoxib16$789$49
Alendronate39$742$19
Loperamide29$670$23
Tamoxifen Citrate19$574$30
Levothyroxine21$548$26
Spironolactone21$542$26
Losartan24$533$22
Chlorthalidone14$483$34
Ketoconazole11$440$40
Prednisone43$413$10
Tamsulosin17$380$22
Lisinopril23$372$16
Lidocaine-Prilocaine25$338$14
Anastrozole18$322$18
Omeprazole12$240$20
Trazodone14$234$17
Escitalopram15$210$14
Metformin12$175$15
Mupirocin11$171$16
Metoprolol11$170$15
Tramadol13$140$11
Lorazepam27$130$5
Hydrocodone-Acetaminophen11$127$12
Furosemide30$117$4
Triamcinolone Acetonide11$107$10
Hydrochlorothiazide12$97$8

2022: 43 drugs

Part D drugs prescribed in 2022
Lenvima22$590,310$26,832
Pomalyst19$404,627$21,296
Imbruvica12$134,295$11,191
Eliquis86$72,165$839
Creon23$36,165$1,572
Xgeva11$31,842$2,895
Plenamine16$5,854$366
Sucralfate18$4,085$227
Oxycontin13$3,956$304
Naloxone32$2,515$79
Dexamethasone37$1,935$52
Nystatin28$1,904$68
Ondansetron88$1,530$17
Mirtazapine36$1,143$32
Pantoprazole14$1,110$79
Amlodipine Besylate88$1,094$12
Oxycodone66$1,033$16
Sodium Chloride51$1,022$20
Prochlorperazine Maleate87$1,010$12
Anastrozole28$1,009$36
Lactulose30$896$30
Gabapentin29$889$31
Hydrocodone-Acetaminophen46$872$19
Morphine Sulfate Er38$821$22
Ondansetron14$651$46
Constulose20$635$32
Acyclovir13$558$43
Potassium Chloride21$553$26
Tamoxifen Citrate24$497$21
Lidocaine-Prilocaine27$457$17
Alendronate25$442$18
Atorvastatin20$404$20
Losartan16$386$24
Loperamide16$370$23
Tamsulosin11$356$32
Duloxetine11$324$29
Lorazepam48$281$6
Diclofenac12$253$21
Famotidine19$220$12
Prednisone14$195$14
Zolpidem18$162$9
Furosemide20$97$5
Lisinopril18$45$2

2021: 43 drugs

Part D drugs prescribed in 2021
Pomalyst17$311,995$18,353
Nexavar14$305,452$21,818
Imbruvica17$257,790$15,164
Tagrisso11$184,195$16,745
Xgeva13$35,179$2,706
Eliquis44$29,158$663
Creon12$23,875$1,990
Xarelto17$11,098$653
Sucralfate19$3,496$184
Enoxaparin15$3,017$201
Narcan17$2,330$137
Nystatin22$1,759$80
Morphine Sulfate Er50$1,483$30
Dexamethasone37$1,441$39
Hydrocodone-Acetaminophen33$1,300$39
Tamoxifen Citrate36$1,245$35
Hydroxyurea16$1,090$68
Anastrozole21$1,068$51
Prochlorperazine Maleate72$1,031$14
Oxycodone40$1,030$26
Potassium Chloride20$925$46
Mirtazapine14$746$53
Pantoprazole23$693$30
Lactulose21$668$32
Chlorthalidone11$633$58
Celecoxib12$633$53
Ondansetron38$598$16
Amlodipine Besylate49$515$11
Levothyroxine21$460$22
Lidocaine-Prilocaine14$390$28
Acyclovir20$313$16
Omeprazole16$304$19
Loperamide11$291$26
Gabapentin16$280$18
Alendronate22$236$11
Prednisone21$209$10
Atorvastatin18$194$11
Lorazepam38$172$5
Lisinopril31$151$5
Sulfamethoxazole-Trimethoprim14$132$9
Clonazepam18$117$7
Tramadol13$46$4
Alprazolam11$9$1

2020: 33 drugs

Part D drugs prescribed in 2020
Pomalyst19$348,460$18,340
Xtandi21$215,232$10,249
Tagrisso13$208,718$16,055
Revlimid12$135,272$11,273
Eliquis27$27,058$1,002
Xarelto23$24,542$1,067
Creon21$18,622$887
Sucralfate15$4,029$269
Narcan20$2,575$129
Mirtazapine19$1,841$97
Dexamethasone39$1,470$38
Nystatin20$1,386$69
Tamoxifen Citrate28$1,212$43
Hydroxyurea20$1,194$60
Prochlorperazine Maleate53$1,192$22
Chlorthalidone17$1,116$66
Morphine Sulfate Er25$635$25
Lactulose23$628$27
Ondansetron28$595$21
Clotrimazole11$542$49
Oxycodone28$533$19
Diphenoxylate-Atropine17$458$27
Hydrocodone-Acetaminophen17$412$24
Omeprazole16$387$24
Anastrozole28$359$13
Levothyroxine14$320$23
Acyclovir11$246$22
Amlodipine Besylate37$243$7
Prednisone16$200$13
Lorazepam15$125$8
Potassium Chloride11$88$8
Alendronate11$80$7
Zolpidem11$39$4

2019: 7 drugs

Part D drugs prescribed in 2019
Tagrisso19$291,719$15,354
Nystatin13$772$59
Dexamethasone14$536$38
Morphine Sulfate Er14$239$17
Prochlorperazine Maleate15$232$15
Ondansetron14$168$12
Lorazepam11$27$2

2018: 9 drugs

Part D drugs prescribed in 2018
Tagrisso13$225,631$17,356
Creon14$14,930$1,066
Nystatin20$874$44
Oxycodone25$576$23
Ondansetron21$506$24
Dexamethasone20$439$22
Pantoprazole14$309$22
Potassium Chloride14$135$10
Lorazepam15$75$5

2017: 9 drugs

Part D drugs prescribed in 2017
Xtandi14$140,460$10,033
Zenpep12$5,877$490
Mirtazapine18$1,289$72
Ondansetron30$711$24
Nystatin24$585$24
Oxycodone23$511$22
Prochlorperazine Maleate31$484$16
Dexamethasone20$207$10
Lorazepam13$89$7

Money from drug and device companies

$1,226 in 2025

Industry payments by year
2025810$925$1,226
202445$3,642$3,667
202378$43,795$43,816
202244$1,283$1,316
202179$1,317$1,493
2020714$25,269$25,428
20191731$21,363$22,055

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
TerSera TherapeuticsMargenza$452
1 payment
  • Consulting for Margenza · 2025-05-20 · $452
Dr.Reddy's LaboratoriesNone$260
1 payment
  • Consulting · 2025-03-11 · $260
Leica MicrosystemsNone$213
1 payment
  • Paid to speak or teach · 2025-09-08 · $213
AstraZeneca Pharmaceuticals LPLynparza$121
1 payment
  • Meals for Lynparza · 2025-12-04 · $121
CelgeneReblozyl$87
3 payments
  • Meals for Reblozyl · 2025-10-07 · $31
  • Meals for Reblozyl · 2025-10-02 · $24
  • Meals for Reblozyl · 2025-03-20 · $32
PfizerPadcev$37
1 payment
  • Meals for Padcev · 2025-10-09 · $37
See all 10 published payments
Every published payment
AstraZeneca Pharmaceuticals LPMeals · 2025-12-04Lynparza$121
PfizerMeals · 2025-10-09Padcev$37
CelgeneMeals · 2025-10-07Reblozyl$31
CelgeneMeals · 2025-10-02Reblozyl$24
Astellas Pharma USMeals · 2025-09-18Vyloy$30
Leica MicrosystemsPaid to speak or teach · 2025-09-08None$213
TerSera TherapeuticsConsulting · 2025-05-20Margenza$452
Adc Therapeutics AmericaMeals · 2025-04-16Zynlonta$26
CelgeneMeals · 2025-03-20Reblozyl$32
Dr.Reddy's LaboratoriesConsulting · 2025-03-11None$260
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $3,667

Payments by company in 2024
AstraZeneca Pharmaceuticals LPLynparza$2,745
2 payments
  • Consulting for Lynparza · 2024-08-26 · $525
  • Consulting for Lynparza · 2024-05-30 · $2,220
BeiGene USANone$517
1 payment
  • Consulting · 2024-05-16 · $517
HalozymeNone$380
1 payment
  • Consulting · 2024-01-06 · $380
PfizerPadcev$25
1 payment
  • Meals for Padcev · 2024-04-25 · $25

2023: $43,816

Payments by company in 2023
Foundation MedicineFoundationone Cdx$40,649
2 payments
  • Paid to speak or teach for Foundationone Cdx · 2023-01-05 · $39,379
  • Paid to speak or teach for Foundationone Cdx · 2023-01-05 · $1,270
AstraZeneca Pharmaceuticals LPImfinzi$1,388
1 payment
  • Consulting for Imfinzi · 2023-10-24 · $1,388
Lantheus Medical ImagingNone$550
1 payment
  • Consulting · 2023-11-14 · $550
Becton Dickinson andNone$508
1 payment
  • Consulting · 2023-08-25 · $508
BeiGeneBrukinsa$500
1 payment
  • Consulting for Brukinsa · 2023-03-08 · $500
Daiichi SankyoNone$200
1 payment
  • Honoraria · 2023-09-05 · $200
Mirati TherapeuticsKrazati$21
1 payment
  • Education for Krazati · 2023-03-16 · $21

2022: $1,316

Payments by company in 2022
Vertex PharmaceuticalsNone$533
1 payment
  • Consulting · 2022-03-11 · $533
BeiGene USABrukinsa$500
1 payment
  • Consulting for Brukinsa · 2022-10-27 · $500
Alexion PharmaceuticalsNone$250
1 payment
  • Paid to speak or teach · 2022-02-15 · $250
GlaxoSmithKlineZejula$33
1 payment
  • Meals for Zejula · 2022-01-27 · $33

2021: $1,493

Payments by company in 2021
GenzymeCablivi$700
2 payments
  • Paid to speak or teach for Cablivi · 2021-11-30 · $350
  • Paid to speak or teach · 2021-07-01 · $350
Vertex PharmaceuticalsNone$517
1 payment
  • Consulting · 2021-06-02 · $517
GlaxoSmithKlineNone$100
1 payment
  • Consulting · 2021-01-15 · $100
Janssen BiotechErleada$100
1 payment
  • Education for Erleada · 2021-07-21 · $100
Pharmacyclics LLC An AbbVieImbruvica$37
2 payments
  • Meals for Imbruvica · 2021-10-20 · $13
  • Meals for Imbruvica · 2021-10-19 · $24
Genentech USARituxan$20
1 payment
  • Meals for Rituxan · 2021-06-28 · $20
Merck Sharp & DohmeKeytruda$19
1 payment
  • Meals for Keytruda · 2021-04-12 · $19

2020: $25,428

Payments by company in 2020
Foundation MedicineFoundationone Cdx$24,844
3 payments
  • Consulting for Foundationone Cdx · 2020-08-18 · $12,997
  • Consulting for Foundationone Liquid · 2020-03-13 · $7,191
  • Consulting for Foundationone Liquid · 2020-01-10 · $4,656
GlaxoSmithKlineZejula$468
4 payments
  • Consulting for Zejula · 2020-10-05 · $425
  • Meals for Zejula · 2020-09-11 · $14
  • Meals for Zejula · 2020-07-27 · $12
  • Meals for Zejula · 2020-01-14 · $17
PfizerXalkori$38
3 payments
  • Education for Inlyta · 2020-08-19 · $13
  • Education for Lorbrena · 2020-02-26 · $11
  • Education for Xalkori · 2020-02-26 · $14
E.R. Squibb & Sons L.L.C.Opdivo$23
1 payment
  • Meals for Opdivo · 2020-02-11 · $23
AbbVieVenclexta$22
1 payment
  • Meals for Venclexta · 2020-11-12 · $22
AstraZeneca Pharmaceuticals LPImfinzi$19
1 payment
  • Meals for Imfinzi · 2020-11-10 · $19
Kite PharmaYescarta$14
1 payment
  • Meals for Yescarta · 2020-01-14 · $14

2019: $22,055

Payments by company in 2019
Foundation MedicineFoundationone Liquid$21,268
2 payments
  • Consulting for Foundationone Liquid · 2019-10-03 · $5,645
  • Consulting for Foundationone Liquid · 2019-02-28 · $15,623
GenzymeElitek$164
6 payments
  • Paid to speak or teach for Elitek · 2019-11-23 · $25
  • Meals for Elitek · 2019-11-04 · $20
  • Meals for Elitek · 2019-10-14 · $25
  • Paid to speak or teach for Elitek · 2019-09-18 · $45
  • Meals for Elitek · 2019-08-26 · $24
  • Paid to speak or teach for Elitek · 2019-08-10 · $25
Bayer HealthCare PharmaceuticalsVitrakvi$124
1 payment
  • Meals for Vitrakvi · 2019-11-06 · $124
Sanofi-Aventis U.S.Jevtana$100
1 payment
  • Education for Jevtana · 2019-08-26 · $100
AstraZeneca Pharmaceuticals LPTagrisso$60
3 payments
  • Meals for Tagrisso · 2019-10-22 · $24
  • Meals for Lynparza · 2019-08-06 · $16
  • Meals for Tagrisso · 2019-07-18 · $20
Janssen BiotechDarzalex$47
3 payments
  • Meals for Erleada · 2019-09-13 · $14
  • Meals for Darzalex · 2019-07-23 · $17
  • Meals for Darzalex · 2019-07-22 · $17
Seattle GeneticsAdcetris$43
2 payments
  • Meals · 2019-09-25 · $21
  • Meals for Adcetris · 2019-07-02 · $22
EisaiHalaven$41
2 payments
  • Meals for Lenvima · 2019-10-24 · $19
  • Meals for Halaven · 2019-08-22 · $22
PfizerBavencio$39
3 payments
  • Education for Braftovi · 2019-11-05 · $13
  • Education for Bavencio · 2019-10-18 · $15
  • Education for Lorbrena · 2019-10-18 · $11
AmgenMvasi$23
1 payment
  • Meals for Mvasi · 2019-07-30 · $23
Daiichi SankyoInjectafer$23
1 payment
  • Meals for Injectafer · 2019-10-31 · $23
Pharmacyclics LLC An AbbVieImbruvica$22
1 payment
  • Meals for Imbruvica · 2019-09-24 · $22
Ipsen BiopharmaceuticalsSomatuline Depot$22
1 payment
  • Meals for Somatuline Depot · 2019-06-12 · $22
E.R. Squibb & Sons L.L.C.Opdivo$21
1 payment
  • Meals for Opdivo · 2019-08-29 · $21
Lilly USAVerzenio$20
1 payment
  • Meals for Verzenio · 2019-09-17 · $20
Dova PharmaceuticalsDoptelet$19
1 payment
  • Meals for Doptelet · 2019-11-19 · $19
Kyowa KirinPoteligeo$17
1 payment
  • Meals for Poteligeo · 2019-06-24 · $17

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Boehringer Ingelheim Pharmaceuticals, Inc. · Phase I Bi907828 in Advance Tp53wt Mdm2 Amplified · 2019Their institution$62,000
Incyte Corporation · A Phase 1a1b Study Exploring the Safety and Tolerability of Incb081776 in Participants With Advanced Malignancies · 2019Their institution$23,294
E.R. Squibb & Sons, L.L.C. · Ph I II Fih Mono and Combo Nlrp3 Nivo Ipi in Advanced Solid Tumors · 2019Their institution$9,809
E.R. Squibb & Sons, L.L.C. · Ph I II Fih Mono and Combo Nlrp3 Nivo Ipi in Advanced Solid Tumors · 2020Their institution$2,407
E.R. Squibb & Sons, L.L.C. · Ph I/II Fih Mono and Combo (Nlrp3 + Nivo + Ipi) in Advanced Solid Tumors · 2022Their institution$122
E.R. Squibb & Sons, L.L.C. · Ph I/II Fih Mono and Combo (Nlrp3 + Nivo + Ipi) in Advanced Solid Tumors · 2023Their institution$78

Professional record

NPI
1912167420
Licence
CA A143956, MA L-236527California A143956: Current · expires 2027-09-30
Trained
Johns Hopkins University School of Medicine, 2008
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Medical oncology (207RX0202X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Palo Alto, CA, 94304
NPI first listed
2008-06-10
NPI last updated
2024-04-28
NPI record certified
2024-04-28

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: Massachusetts General Hospital, Boston, MA, 02114